3 Einträge gefunden

1. Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study

   1. Gambacorti-Passerini, Carlo
   2. Cortes, Jorge E
   3. Lipton, Jeff H
   4. Kantarjian, Hagop M
   5. Kim, Dong-Wook
   6. Schafhausen, Philippe
   7. Crescenzo, Rocco

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
2. Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib

   1. Brümmendorf, Tim H
   2. Cortes, Jorge E
   3. Khoury, Hanna J
   4. Kantarjian, Hagop M
   5. Kim, Dong-Wook
   6. Schafhausen, Philippe
   7. Conlan, Maureen G

   2016 - Forschungsinformationssystem des UKE
3. Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors

   1. Gambacorti-Passerini, Carlo
   2. Kantarjian, Hagop M
   3. Kim, Dong-Wook
   4. Khoury, Hanna J
   5. Turkina, Anna G
   6. Brümmendorf, Tim H
   7. Matczak, Ewa

   2015 - Forschungsinformationssystem des UKE